Research programme: antibacterials - Ferrer
Alternative Names: GF-013062-00; GF-016469-00; GF-016509-00Latest Information Update: 04 Nov 2017
At a glance
- Originator Ferrer
- Class Oxazolidinones
- Mechanism of Action Protein synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Gram-positive infections
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Gram-positive-infections in Spain (Topical)
- 09 Jan 2009 Preclinical development is ongoing in Spain
- 03 Oct 2007 Preclinical development is ongoing